Today on the Biorasi Few & Far Between podcast:

Host Melissa Alesse welcomes Isaac Stoner, CEO of MindImmune Therapeutics, back to the podcast for a conversation on the evolving science of Alzheimer's disease and the challenges of biotech leadership.

We'll explore Alzheimer's through the lens of the immune system, discuss drug development from the perspective of investors and operators, and dive into the power of networking in Boston's biotech ecosystem. And be sure to stick around for our lightning round - quick answers to important questions.

Watch this episode today!